Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-3470.66%
operating margin TTM
-3809.18%
revenue TTM
3.50 Million
revenue per share TTM
0.06$
valuation ratios | |
|---|---|
| pe ratio | -42.71 |
| peg ratio | 19.07 |
| price to book ratio | 7.19 |
| price to sales ratio | 1,506.89 |
| enterprise value multiple | -43.83 |
| price fair value | 7.19 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -3809.18% |
| pretax profit margin | -3432.14% |
| net profit margin | -3470.66% |
| return on assets | -15.03% |
| return on equity | -16.57% |
| return on capital employed | -17.69% |
liquidity ratio | |
|---|---|
| current ratio | 12.80 |
| quick ratio | 12.50 |
| cash ratio | 12.33 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.50 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.04 |
| debt equity ratio | 0.04 |
| long term debt to capitalization | 0.03 |
| total debt to capitalization | 0.04 |
| interest coverage | -212.30 |
| cash flow to debt ratio | -3.04 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.53 |
| cash per share | 3.62 |
| operating cash flow per share | -0.51 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -3.04 |
| short term coverage ratios | -16.72 |
| capital expenditure coverage ratio | -29.63 |
Frequently Asked Questions
When was the last time Ambrx Biopharma Inc. (NYSE:AMAM) reported earnings?
Ambrx Biopharma Inc. (AMAM) published its most recent earnings results on 30-09-2023.
What is Ambrx Biopharma Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ambrx Biopharma Inc. (NYSE:AMAM)'s trailing twelve months ROE is -16.57%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ambrx Biopharma Inc. (AMAM) currently has a ROA of -15.03%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AMAM's net profit margin stand at?
AMAM reported a profit margin of -3470.66% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AMAM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 12.80 in the most recent quarter. The quick ratio stood at 12.50, with a Debt/Eq ratio of 0.04.